Arthritis
📧 Sign up to get email alerts when something new happens for Arthritis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-07-28EMA Withdrawn: Inflectra (infliximab) — Pfizer Europe MA EEIG
The EMA has withdrawn Inflectra (infliximab) from the market.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Rheumatoid Arthritis
ProgenaBiome's pilot trial examining the role of gut flora in rheumatoid arthritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-10-26Clinical Trial Update: Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty [Phase 4]
A Phase 4 clinical trial evaluating single versus multi-dose oral tranexamic acid in high-risk patients for blood transfusion after total jo…
-
EMA withdrawal · 2021-03-19EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd
EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.
-
EMA withdrawal · 2020-02-20EMA Lapsed: Lifmior (etanercept) — Pfizer Europe MA EEIG
The European Medicines Agency indicates Lifmior (etanercept) has lapsed; the product is no longer active in the market for its indicated con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-05-16Clinical Trial Update: Regulating Urine pH Levels to Alleviate Chronic Joint Pain [Phase 1]
A Phase 1 clinical trial investigating whether regulating urine pH levels can alleviate chronic joint pain (arthritis) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-27Clinical Trial Update: Patello-Femoral Joint Post Market Clinical Follow-up Within the Knee Registry
A post-market clinical follow-up study in the patellofemoral joint within the knee registry has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-06-28Clinical Trial Update: Anterior Tibiotalar Arthrodesis With Blade Plate Fixation
A clinical trial evaluating anterior tibiotalar arthrodesis with blade plate fixation, sponsored by the University of Utah, has been withdra…
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: Observational Study of Total Ankle Arthroplasty and Tibiotalar Arthrodesis
This notification reports the withdrawal of an observational study evaluating total ankle arthroplasty and tibiotalar arthrodesis for arthri…
-
CLINICAL_TRIALS withdrawal · 2015-06-26Clinical Trial Update: Intraarticular Injection of Infliximab [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating intraarticular infliximab for arthritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-22Clinical Trial Update: INBONE™ Total Ankle Prosthesis With Long Talar Stem [NA]
The INBONE Total Ankle Prosthesis with Long Talar Stem clinical trial has been terminated; no results are provided in this update.
-
CLINICAL_TRIALS withdrawal · 2014-04-03Clinical Trial Update: Serologic Characterization of Bone-healing
A clinical trial investigating serologic characterization of bone healing in arthritis patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-24Clinical Trial Update: Surgical Lavage vs Serial Needle Aspiration for Infected Joints [Phase 3]
A Phase 3 trial comparing surgical lavage to serial needle aspiration for infected joints was withdrawn. The study was sponsored by Emory Un…
-
EMA withdrawal · 2010-02-03EMA Withdrawn: Bextra (valdecoxib) — Pharmacia - Pfizer EEIG
The EMA indicates Bextra (valdecoxib) has been withdrawn from the market by Pharmacia - Pfizer EEIG.